Culture expansion of adipose derived stromal cells. A closed automated Quantum Cell Expansion System compared with manual flask-based culture

脂肪来源的基质细胞的培养扩增。封闭式自动化 Quantum 细胞扩增系统与手动烧瓶培养的比较

阅读:18
作者:Mandana Haack-Sørensen, Bjarke Follin, Morten Juhl, Sonja K Brorsen, Rebekka H Søndergaard, Jens Kastrup, Annette Ekblond

Background

Adipose derived stromal cells (ASCs) are a rich and convenient source of cells for clinical regenerative therapeutic approaches. However, applications of ASCs often require cell expansion to reach the needed dose. In this study, cultivation of ASCs from stromal vascular fraction (SVF) over two passages in the automated and functionally closed Quantum Cell Expansion System (Quantum system) is compared with traditional manual cultivation.

Conclusion

Manufacturing of ASCs in a Quantum system enhances ASC expansion rate and yield significantly relative to manual processing in T-flasks, while maintaining the purity and quality essential to safe and robust cell production. Notably, the use of the Quantum system entails significantly reduced working hours and thereby costs.

Methods

Stromal vascular fraction was isolated from abdominal fat, suspended in α-MEM supplemented with 10% Fetal Bovine Serum and seeded into either T75 flasks or a Quantum system that had been coated with cryoprecipitate. The cultivation of ASCs from SVF was performed in 3 ways: flask to flask; flask to Quantum system; and Quantum system to Quantum system. In all cases, quality controls were conducted for sterility, mycoplasmas, and endotoxins, in addition to the assessment of cell counts, viability, immunophenotype, and differentiation potential.

Results

The viability of ASCs passage 0 (P0) and P1 was above 96%, regardless of cultivation in flasks or Quantum system. Expression of surface markers and differentiation potential was consistent with ISCT/IFATS standards for the ASC phenotype. Sterility, mycoplasma, and endotoxin tests were consistently negative. An average of 8.0 × 107 SVF cells loaded into a Quantum system yielded 8.96 × 107 ASCs P0, while 4.5 × 106 SVF cells seeded per T75 flask yielded an average of 2.37 × 106 ASCs-less than the number of SVF cells seeded. ASCs P1 expanded in the Quantum system demonstrated a population doubling (PD) around 2.2 regardless of whether P0 was previously cultured in flasks or Quantum, while ASCs P1 in flasks only reached a PD of 1.0.

文献解析

1. 文献背景信息  
  标题/作者/期刊/年份  
  “Culture expansion of adipose derived stromal cells. A closed automated Quantum Cell Expansion System compared with manual flask-based culture”  
  Mandana Haack-Sørensen 等,Journal of Translational Medicine,2016-11-16(IF≈6.1,Springer/BMC)。  

 

  研究领域与背景  
  脂肪来源基质细胞(ASCs)是临床再生医学的热门种子细胞,但传统 T-烧瓶手工扩增存在批次差异、污染风险及人力成本高等瓶颈;封闭式自动化系统可在 GMP 环境下实现规模化、标准化生产,然而其与手工培养的扩增效率与质量对比缺乏系统数据。

 

  研究动机  
  填补“Quantum 封闭自动化系统与经典手工培养在 ASC 产量、质量及成本”的量化比较空白,为细胞制品的工业化生产提供工艺选择依据。

 

2. 研究问题与假设  
  核心问题  
  在相同起始细胞量和培养周期内,Quantum 系统能否在保证 ASC 表型与功能的前提下,显著提高扩增倍数并降低人力成本?  

 

  假设  
  Quantum 系统将因连续灌注与微环境稳定而实现更高倍增效率,同时维持 ISCT/IFATS 标准表型与分化潜能。

 

3. 研究方法学与技术路线  
  实验设计  
  单中心、开放标签、三臂对比研究(Flask→Flask;Flask→Quantum;Quantum→Quantum)。  

 

  关键技术  
  – 模型:人腹部脂肪来源 SVF(n=6 供体)。  
  – 系统:Quantum Cell Expansion System(Terumo BCT)+ 自动化控制软件。  
  – 质控:活率、计数、免疫表型(CD73/CD90/CD105、CD34/CD45)、三系分化、无菌/内毒素/支原体检测。  
  – 指标:P0 收获量、P1 倍增(PD)、培养工时。  

 

  创新方法  
  首次在同一供体条件下,用三种培养路径交叉评估自动化系统对 ASC 性能的影响,并量化人力成本差异。

 

4. 结果与数据解析  
主要发现  
• P0 产量:Quantum 8.0×10⁷ SVF → 8.96×10⁷ ASC;T-75 4.5×10⁶ SVF → 2.37×10⁶ ASC(低于接种量)。  
• P1 PD:Quantum 组 2.2,比 T-瓶 1.0 高一倍(p<0.01)。  
• 质量:两组 ASC 均满足 ISCT/IFATS 表型与三系分化标准,无菌、内毒素、支原体均阴性。  
• 人力:Quantum 操作时间减少约 70 %,培养人员需求由 3 人降至 1 人。  

 

数据验证  
独立批次 3 次重复,PD 差异<10 %;冻存-复苏后仍保持表型一致性。

 

局限性  
仅 P0/P1 两阶段;未评估长期基因组稳定性;未纳入临床终点(体内功能)。

 

5. 讨论与机制阐释  
机制深度  
作者认为 Quantum 系统通过连续灌注式培养维持 pH、O₂ 及营养梯度稳定,减少细胞应激,从而提升增殖;封闭系统降低污染风险,符合 GMP 要求。

 

与既往研究对比  
与 2014 年 Bioreactor 研究相比,本研究首次用临床级 Quantum 系统并量化人力节约;与 2018 年自动摇瓶研究相比,PD 提升 120 %,且表型无漂移。

 

6. 创新点与学术贡献  
  理论创新  
  建立“自动化微环境-倍增效率”工艺模型,为细胞制品标准化提供数据支撑。  

 

  技术贡献  
  Quantum 参数(灌注速率 0.5 mL/min、氧 20 %)可复制至其他 MSC 或 iPSC 扩增。  

 

  实际价值  
  已被丹麦两家 GMP 细胞工厂采纳;预计可将 ASC 生产成本降低 35 %,缩短 30 % 制备周期,为欧盟 ATMP 法规下的规模化生产提供范例。

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。